Orlistat in Line for Approval as Japan’s 1st Nonprescription Obesity Drug after 4-Year Review

November 29, 2022
A health ministry panel on November 28 cleared what is now set to be the first nonprescription obesity treatment in Japan. The drug is expected to gain the official stamp of approval at the end of March next year, exactly...read more